Literature DB >> 6099378

Endocrine studies on ovarian androblastomas (Sertoli-Leydig tumors).

M Munemura, S Inoue, R Himeno, N Koyama, J Mizumoto, M Maeyama, T Iwamasa.   

Abstract

Endocrine studies were made on 4 women with ovarian Sertoli-Leydig cell tumors of varying degrees of differentiation. Clinically, all 4 patients showed evidence of increased androgen production, manifested by either hirsutism or virilization. The calculated ratios of steroid hormones between the affected ovarian venous values and peripheral values for testosterone (T), androstenedione (A), and dehydroepiandrosterone (DHEA) in 3 patients, were 1.4-18.6, 4.2-24.4, and 3.7-10.0, respectively. The peripheral levels of the hormones before salpingo-oophorectomy in all the patients were T: 0.97-45.0 ng/ml; A: 2.92-114.0 ng/ml; and DHEA: 13.0-20.9 ng/ml. In the 3 juvenile patients, elevated basal levels of LH and normal or subnormal levels of FSH (high LH:FSH ratio) were found. In a 12-year-old patient with 1,900 g tumor composed predominantly of Sertoli cells with lipid storage, the peripheral serum levels of T and estradiol (E2) were 114 ng/ml and 1890 pg/ml, respectively. The present data suggest that: 1) androblastomas have a biosynthetic capacity for androgen, estrogen, or both in which both the delta 5 and delta 4 pathways are involved, and 2) little correlation exists between the endocrine function and cellular composition of the tumors or their degree of differentiation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6099378     DOI: 10.1007/BF03349495

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  STEROID SYNTHESIS IN ABNORMAL OVARIES. 1. ARRHENOBLASTOMA.

Authors:  N KASE; S H CONRAD
Journal:  Am J Obstet Gynecol       Date:  1964-12-15       Impact factor: 8.661

2.  The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma.

Authors:  R H SILBER; C C PORTER
Journal:  J Biol Chem       Date:  1954-10       Impact factor: 5.157

3.  The determination of urinary steroids. I. The preparation of pigment-free extracts and a simplified procedure for the estimation of total 17-ketosteroids.

Authors:  I J DREKTER; A HEISLER; G R SCISM; S STERN; S PEARSON; T H McGAVACK
Journal:  J Clin Endocrinol Metab       Date:  1952-01       Impact factor: 5.958

4.  Arrhenoblastoma: in vivo and in vitro studies.

Authors:  E V Younglai; H Richmond; R Atyeo; F L Johnson
Journal:  Am J Obstet Gynecol       Date:  1973-06-01       Impact factor: 8.661

5.  Arrhenoblastoma: three case reports.

Authors:  R B Greenblatt; V B Mahesh; R D Gambrell
Journal:  Obstet Gynecol       Date:  1972-04       Impact factor: 7.661

6.  A clinical and metabolic study of masculinizing arrhenoblastoma.

Authors:  T Sato; T Shinada; S Matsumoto
Journal:  Am J Obstet Gynecol       Date:  1969-08-15       Impact factor: 8.661

7.  Peripheral and Ovarian Steroids in Ovarian Hyperthecosis.

Authors:  G E Abraham; J E Buster
Journal:  Obstet Gynecol       Date:  1976-05       Impact factor: 7.661

8.  An immunohistological study of steroid localization in Sertoli-Leydig tumors of the ovary and testis.

Authors:  R J Kurman; D Andrade; U Goebelsmann; C R Taylor
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

9.  The steroid profile of a virilizing ovarian tumor.

Authors:  M R Soules; G E Abraham; E H Bossen
Journal:  Obstet Gynecol       Date:  1978-07       Impact factor: 7.661

10.  Androgen, estrogen, and progesterone by a lipid cell tumor of theovary.

Authors:  L M Bonaventura; H Judd; L M Roth; R E Cleary
Journal:  Am J Obstet Gynecol       Date:  1978-06-15       Impact factor: 8.661

View more
  3 in total

1.  Clinical features and hormonal characteristics in a case of ovarian arrhenoblastoma.

Authors:  P Tita; A Spina; G Briguglia; A Magro; D Gallo; C Finocchiaro; G Padova; V Pezzino
Journal:  J Endocrinol Invest       Date:  1996 Jul-Aug       Impact factor: 4.256

2.  Luteinizing hormone pulsatility in patients with major ovarian hyperandrogenism.

Authors:  A Bachelot; K Laborde; J L Bresson; G Plu-Bureau; A Raynaud; X Bertagna; A Mogenet; M Mansour; V Lucas-Jouy; J-P Gayno; Y Reznik; J-M Kuhn; L Billaud; M-C Vacher-Lavenu; M Putterman; I Mowszowicz; P Touraine; F Kuttenn
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

3.  Changing pattern of gonadotropins in a patient with an adrenal-androgen secreting tumor.

Authors:  Jose Antonio Miguel Marcondes; Cristiano R G Barcellos; Michelle P Rocha; Hélio Bisi
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.